[For or against the early use of nasal continuous positive pressure and exogenous surfactant in hyaline membrane disease. Physiopathologic arguments]

L Storme; P Truffert; T Rakza; P Lequien

doi:10.1016/s0929-693x(99)80564-8

[For or against the early use of nasal continuous positive pressure and exogenous surfactant in hyaline membrane disease. Physiopathologic arguments]

Arch Pediatr. 1999 May;6(5):549-55. doi: 10.1016/s0929-693x(99)80564-8.

[Article in French]

Authors

L Storme¹, P Truffert, T Rakza, P Lequien

Affiliation

¹ Service de médecine néonatale, Hôpital Jeanne-de-Flandre, CHRU de Lille, France.

PMID: 10370813
DOI: 10.1016/s0929-693x(99)80564-8

Abstract

The use of nasal CPAP in the treatment of respiratory distress syndrome in very premature newborns follows pathophysiological basis. The authors emphasize the usefulness of nasal CPAP and surfactant in the treatment of respiratory distress syndrome. The aim of this strategy is to reduce alveolar atelectasis, thus reducing the incidence and the severity of respiratory distress syndrome, together with a possible reduction of the incidence of bronchopulmonary dysplasia.

Publication types

English Abstract
Review

MeSH terms

Bronchopulmonary Dysplasia / physiopathology
Bronchopulmonary Dysplasia / prevention & control
Humans
Hyaline Membrane Disease / physiopathology
Hyaline Membrane Disease / therapy*
Infant, Newborn
Infant, Premature
Positive-Pressure Respiration*
Pulmonary Alveoli / physiopathology
Pulmonary Atelectasis / physiopathology
Pulmonary Atelectasis / prevention & control
Pulmonary Surfactants / therapeutic use*
Respiratory Distress Syndrome, Newborn / physiopathology
Respiratory Distress Syndrome, Newborn / prevention & control

Substances

Pulmonary Surfactants